Herpetic neuralgia
Conditions
Interventions
Experimental group:Interferon-a1B and lidocaine were injected into the target
Control group:methyltoluene and lidocaine were injected into the target
Sponsors
The First Hospital of Shanxi Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Herpetic neuralgia with a course less than 3 months; 2. The trigeminal ganglion and cerviothoracic lumbosacral ganglion were involved, NRS > 4; 3. Age above 50 years old, under 80 years old, gender is not limited; 4. Volunteer to participate in the study and sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Herpes infection at the puncture site; 2. Oar herpes zoster, central nervous system invasion and disseminated herpes zoster and other special clinical types; 3. Allergic to interferon alpha and methylprednisolone sodium succinate; 4. Coagulation dysfunction, severe heart, liver and renal insufficiency; 5. Patients with congenital immunodeficiency or immunodeficiency and serious diseases such as tuberculosis and tumor; 6. People with poor coordination with mental disorders (including those who cannot perform NRS and sleep quality scores); 7. The researcher did not consider it appropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale;Incidence of postherpetic neuralgia; | — |
Secondary
| Measure | Time frame |
|---|---|
| PSQI;Number of nerve block treatments;Total dose of basic drugs; | — |
Countries
China
Contacts
Public ContactXue Zhaoxia
The First Hospital of Shanxi Medical University
Outcome results
None listed